Unknown

Dataset Information

0

Experimental Malaria in Pregnancy Induces Neurocognitive Injury in Uninfected Offspring via a C5a-C5a Receptor Dependent Pathway.


ABSTRACT: The in utero environment profoundly impacts childhood neurodevelopment and behaviour. A substantial proportion of pregnancies in Africa are at risk of malaria in pregnancy (MIP) however the impact of in utero exposure to MIP on fetal neurodevelopment is unknown. Complement activation, in particular C5a, may contribute to neuropathology and adverse outcomes during MIP. We used an experimental model of MIP and standardized neurocognitive testing, MRI, micro-CT and HPLC analysis of neurotransmitter levels, to test the hypothesis that in utero exposure to malaria alters neurodevelopment through a C5a-C5aR dependent pathway. We show that malaria-exposed offspring have persistent neurocognitive deficits in memory and affective-like behaviour compared to unexposed controls. These deficits were associated with reduced regional brain levels of major biogenic amines and BDNF that were rescued by disruption of C5a-C5aR signaling using genetic and functional approaches. Our results demonstrate that experimental MIP induces neurocognitive deficits in offspring and suggest novel targets for intervention.

SUBMITTER: McDonald CR 

PROVIDER: S-EPMC4581732 | biostudies-literature | 2015 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

Experimental Malaria in Pregnancy Induces Neurocognitive Injury in Uninfected Offspring via a C5a-C5a Receptor Dependent Pathway.

McDonald Chloë R CR   Cahill Lindsay S LS   Ho Keith T KT   Yang Jimmy J   Kim Hani H   Silver Karlee L KL   Ward Peter A PA   Mount Howard T HT   Liles W Conrad WC   Sled John G JG   Kain Kevin C KC  

PLoS pathogens 20150924 9


The in utero environment profoundly impacts childhood neurodevelopment and behaviour. A substantial proportion of pregnancies in Africa are at risk of malaria in pregnancy (MIP) however the impact of in utero exposure to MIP on fetal neurodevelopment is unknown. Complement activation, in particular C5a, may contribute to neuropathology and adverse outcomes during MIP. We used an experimental model of MIP and standardized neurocognitive testing, MRI, micro-CT and HPLC analysis of neurotransmitter  ...[more]

Similar Datasets

2010-05-26 | E-GEOD-9497 | biostudies-arrayexpress
2008-01-31 | GSE9497 | GEO
2019-07-01 | GSE118089 | GEO
| S-EPMC3946361 | biostudies-literature
| S-EPMC5561130 | biostudies-literature
| S-EPMC8478258 | biostudies-literature
| S-EPMC4244017 | biostudies-literature
| S-EPMC9709022 | biostudies-literature
| S-EPMC8007412 | biostudies-literature
| S-EPMC3836463 | biostudies-literature